CG
BMY icon

CFO4Life Group’s Bristol-Myers Squibb BMY Stock Holding History

CFO4Life Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,672
Closed -$285K – 232
2025
Q1 		$285K Buy
4,672
+322
+7% +$18.8K 0.05% 164
2024
Q4 		$246K Sell
4,350
-38
-0.9% -$2.12K 0.04% 179
2024
Q3 		$227K Buy
+4,388
New +$206K 0.04% 184
2024
Q2 		– Sell
-4,300
Closed -$233K – 208
2024
Q1 		$233K Buy
+4,300
New +$219K 0.04% 169
2023
Q4 		– Sell
-3,891
Closed -$226K – 188
2023
Q3 		$226K Buy
3,891
+123
+3% +$7.54K 0.05% 138
2023
Q2 		$241K Buy
3,768
+332
+10% +$22.3K 0.05% 143
2023
Q1 		$238K Sell
3,436
-401
-10% -$28.3K 0.05% 141
2022
Q4 		$276K Buy
3,837
+306
+9% +$23.1K 0.06% 140
2022
Q3 		$251K Sell
3,531
-181
-5% -$13.1K 0.07% 115
2022
Q2 		$274K Sell
3,712
-22
-0.6% -$1.68K 0.07% 118
2022
Q1 		$273K Buy
3,734
+25
+0.7% +$1.68K 0.06% 125
2021
Q4 		$231K Sell
3,709
-768
-17% -$45.1K 0.05% 136
2021
Q3 		$265K Buy
4,477
+270
+6% +$17.8K 0.06% 121
2021
Q2 		$281K Sell
4,207
-11
-0.3% -$717 0.06% 114
2021
Q1 		$266K Sell
4,218
-6,938
-62% -$432K 0.07% 123
2020
Q4 		$692K Buy
11,156
+10
+0.1% +$615 0.2% 57
2020
Q3 		$672K Buy
11,146
+1,895
+20% +$114K 0.23% 51
2020
Q2 		$544K Buy
9,251
+1,475
+19% +$88.2K 0.21% 51
2020
Q1 		$433K Buy
+7,776
New +$475K 0.23% 59
2018
Q1 		– Sell
-3,931
Closed -$241K – 96
2017
Q4 		$241K Hold
3,931
– – 0.19% 85
2017
Q3 		$251K Buy
+3,931
New +$230K 0.2% 85

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CFO4Life Group's BMY Position: Q2 2025 in Review

CFO4Life Group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,672 shares — an estimated $285K sold.

CFO4Life Group first reported a position in BMY in Q3 2017 and held it in 21 quarters. The position peaked at $692K in Q4 2020. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • CFO4Life Group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • CFO4Life Group sold 4,672 Bristol-Myers Squibb shares in Q2 2025, an estimated $285K.
  • CFO4Life Group first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 21 quarters.
  • CFO4Life Group's Bristol-Myers Squibb position peaked at $692K in Q4 2020.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on CFO4Life Group's 13F filing for Q2 2025, filed 8 Aug 2025.